中文 | English
Return
Total: 45 , 1/5
Show Home Prev Next End page: GO
MeSH:(Taxoids/adverse effects/*therapeutic use)

1.Evaluation of two different regimens as neoadjuvant chemotherapy for breast cancer.

Deqi YANG ; Fuzhong TONG ; Yingming CAO ; Peng LIU ; Bo ZHOU ; Hongjun LIU ; Xinmin QIAO ; Jiaqing ZHANG

Chinese Journal of Oncology 2002;24(3):303-305

2.Efficacy and toxicity of vinorelbine (NVB)-based regimens in patients with metastatic triple negative breast cancer (mTNBC) pretreated with anthracyclines and taxanes.

Feng DU ; Peng YUAN ; Yang LUO ; Jiayu WANG ; Fei MA ; Ruigang CAI ; Ying FAN ; Qing LI ; Pin ZHANG ; Binghe XU ; Email: XUBINGHE@MEDMAIL.COM.CN.

Chinese Journal of Oncology 2015;37(10):788-792

3.Phase I study of TPF neoadjuvant chemotherapy followed by radical radiotherapy in advanced nasopharyngeal carcinoma.

Ling GUO ; Huan-Xin LIN ; Min XU ; Qiu-Yan CHEN ; Cheng-Tao WANG ; Pei-Yu HUANG

Chinese Journal of Cancer 2010;29(2):136-139

4.A Case of Therapy-related Acute Myeloid Leukemia associated with inv(16).

So Young LEE ; Myungshin KIM ; Jihyang LIM ; Yonggoo KIM ; Kyungja HAN ; Sung Yong KIM ; Hee Je KIM ; In Yang PARK

The Korean Journal of Laboratory Medicine 2007;27(1):19-21

5.Safety and efficacy of first-line bevacizumab combined with taxane therapy in Chinese patients with HER2-negative locally recurrent or metastatic breast cancer: findings from the ATHENA study.

Bing-he XU ; Ze-fei JIANG ; Zhen-zhou SHEN ; Zhong-zhen GUAN ; Zheng-dong CHEN ; Ying CHENG ; Hong ZHENG ; Jun JIANG ; Xiao-jia WANG ; Zhong-sheng TONG ; Shu-kui QIN ; Yi LUO ; Min YAO ; Li-wei WANG ; Jing HE

Chinese Medical Journal 2012;125(5):764-769

6.Therapeutic effects of FOLFOX6 versus TLF regimen as the first line chemotherapy for advanced gastric cancer.

Hong-bo YU ; Hai-bing XIAN ; Yan-ming DENG ; Lu-lin LI

Journal of Southern Medical University 2010;30(10):2373-2376

7.Docetaxel in the treatment of advanced breast cancer .

Zi-Ping WANG ; Yan SUN ; Xiang-Ru ZHANG ; Mao-Hong ZHANG ; Xiu-Wen WANG ; Xue-Jun YU ; Ke-Jun NAN ; En-Xiao LI ; Ji-Wei LIU ; Ya-Jie GAO ; Xiao-Qian GUAN ; Shu-Ping SONG ; Li-Jun SHENG ; Dong-Lin WANG ; Zhi-Xin WANG

Chinese Journal of Oncology 2006;28(6):468-470

8.Docetaxel Chemotherapy of Korean Patients with Hormone-refractory Prostate Cancer: Comparative Analysis between 1st-line and 2nd-line Docetaxel.

Jae Young JOUNG ; In Gab JEONG ; Kyung Seok HAN ; Taek Sang KIM ; Seung Ok YANG ; Ho Kyung SEO ; Jinsoo CHUNG ; Kang Su CHO ; Kang Hyun LEE

Yonsei Medical Journal 2008;49(5):775-782

9.Third-line docetaxel chemotherapy for recurrent and metastatic gastric cancer.

Ji Hyun LEE ; Sung Hyun KIM ; Sung Yong OH ; Suee LEE ; Hojin LEE ; Hye Jung LEE ; Hyo Jin KIM

The Korean Journal of Internal Medicine 2013;28(3):314-321

10.Docetaxel (Taxotere®)-induced cavitary change of pulmonary metastatic lesions complicated by bilateral spontaneous pneumothoraces in a patient with primary adenocarcinoma of the lung.

Hao-Lun KAO ; Wen-Chiung LIN ; Hsian-He HSU ; Guo-Shu HUANG

Singapore medical journal 2013;54(6):e133-4

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 45 , 1/5 Show Home Prev Next End page: GO